The problem of toxoplasmosis in outpatient practice. Part I. Toxoplasmosis in immunocompromised patients

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Toxoplasmosis remains one of the most common opportunistic infections in immunocompromised patients, primarily in people living with HIV. An increase in the number of requests for medical care by patients with HIV infection as the disease progresses determines the need for knowledge of outpatient therapists and general practitioners of decision-making algorithms for suspected toxoplasmosis in such patients. The main clinical manifestations of toxoplasmosis in patients with immunodeficiency states, the formulation of a preliminary diagnosis, and the routing algorithm are given.

作者简介

Valerii Vasiliev

North-Western State Medical University named after I.I. Mechnikov; Pediatric Research and Clinical Center for Infectious Diseases of federal medical and biological agency

编辑信件的主要联系方式.
Email: vcubed@yandex.ru
ORCID iD: 0000-0003-2579-2799
SPIN 代码: 5644-9877
Scopus 作者 ID: 57192667926
Researcher ID: O-4773-2014

MD, Dr. Sci. (Med.), Professor

俄罗斯联邦, Saint Petersburg; Saint Petersburg

Elena Romanova

North-Western State Medical University named after I.I. Mechnikov

Email: asrom@yandex.ru
ORCID iD: 0000-0002-9887-8561
SPIN 代码: 9435-6838
Scopus 作者 ID: 57200549549

MD, Cand. Sci. (Med.), Assistant Professor

俄罗斯联邦, Saint Petersburg

参考

  1. Schlüter D, Barragan A. Advances and challenges in understanding cerebral toxoplasmosis. Front Immunol. 2019;10:(242):1–13. doi: 10.3389/fimmu.2019.00242
  2. Wesołowski R, Pawłowska M, Smoguła M., Szewczyk-Golec K. Advances and challenges in diagnostics of toxoplasmosis in HIV-infected patients. Pathogens. 2023;12(110):1–13. doi: 10.3390/pathogens12010110
  3. Khan’ AV, Kalinina TN, Pan’kov AS, Tuchkov DYu. The structure of the causes of death of patients with hiv infection in 2018-2019 in the infectious hospital in Orenburg. Orenburg medical herald. 2021;9(4(36)):57–60. (In Russ.)
  4. Fernàndez-Sabé N, Cervera C, Fariñas MC, et al. Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case-control study. Clin Infect Dis. 2012;54(3):355–361. doi: 10.1093/cid/cir806
  5. Murakami D, Maki H, Matsuda K, et al. Cerebral toxoplasmosis complicating lymphoplasmacytic lymphoma in partial remission. J Infect Chemother. 2022;28(2):279–282. doi: 10.1016/j.jiac.2021.09.005
  6. Dubey JP, Murata FHA, Cerqueira-Cézar CK, et al. Congenital toxoplasmosis in humans: an update of worldwide rate of congenital infections. Parasitology. 2021;148(12):1406–1416. doi: 10.1017/S0031182021001013
  7. Martin-Iguacel R, Ahlström MG, Touma M, et al. Incidence, presentation and outcome of toxoplasmosis in HIV infected in the combination antiretroviral therapy era. J Infect. 2017;75(3):263–273. doi: 10.1016/j.jinf.2017.05.018
  8. Connolly MP, Haitsma G, Hernández AV, Vidal JE. Systematic review and meta-analysis of secondary prophylaxis for prevention of HIV-related toxoplasmic encephalitis relapse using trimethoprim-sulfamethoxazole. Pathog Glob Health. 2017;111(6):327–331. doi: 10.1080/20477724.2017.1377974
  9. de Barros RAM, Torrecilhas AC, Marciano MAM, et al. Toxoplasmosis in human and animals around the world. Diagnosis and perspectives in the one health approach. Acta Trop. 2022;231:e:106432. doi: 10.1016/j.actatropica.2022.106432
  10. Almeria S, Dubey JP. Foodborne transmission of Toxoplasma gondii infection in the last decade. An overview. Res Vet Sci. 2021;135:371–385. doi: 10.1016/j.rvsc.2020.10.019
  11. Abbasi Fard S, Khajeh A, Khosravi A, et al. Fulminant and diffuse cerebral toxoplasmosis as the first manifestation of hiv infection: a case presentation and review of the literature. Am J Case Rep. 2020;21:e919624. doi: 10.12659/AJCR.919624
  12. Dian S, Ganiem AR, Ekawardhani S. Cerebral toxoplasmosis in HIV-infected patients: a review. Pathog Glob Health. 2023;117(1):14–23. doi: 10.1080/20477724.2022.2083977
  13. Makinson A, Park LS, Stone K, et al. Risks of opportunistic infections in people with human immunodeficiency virus with cancers treated with chemotherapy. Open Forum Infect Dis. 2021;8(8):1–8. doi: 10.1093/ofid/ofab389
  14. Azoulay E, Russell L, Van de Louw A, et al. Diagnosis of severe respiratory infections in immunocompromised patients. Intensive Care Med. 2020;46(2):298–314. doi: 10.1007/s00134-019-05906-5
  15. de-la-Torre A, Gómez-Marín J. Disease of the Year 2019: Ocular toxoplasmosis in HIV-infected patients. Ocul Immunol Inflamm. 2020;28(7):1031–1039. doi: 10.1080/09273948.2020.1735450
  16. Sudharshan S, Nair N, Curi A, et al. Human immunodeficiency virus and intraocular inflammation in the era of highly active antiretroviral therapy – an update. Indian J Ophthalmol. 2020;68(9):1787–1798. doi: 10.4103/ijo.IJO_1248_20
  17. Voznesenskiy SL, Shakhgildyan VI, Petrova EV, et al. Unspecified encephalitis in HIV-infected patients: clinical and postmortem evaluation. Terapevticheskii arkhiv. 2021;93(11):1278–1282. (In Russ.). doi: 10.26442/00403660.2021.11.201197
  18. Washino T, Mikita K, Kosaka A, et al. Disseminated toxoplasmosis associated with haemophagocytic lymphohistiocytosis in a patient with the human immunodeficiency virus: a case report and literature review. Int J Infect Dis. 2022;123:176–179. doi: 10.1016/j.ijid.2022.08.023
  19. Kitahara M, Hiroshima Y, Norose K, et al. Clinical characteristics and incidence of toxoplasmosis after autologous hematopoietic stem cell transplantation: a retrospective study and literature review. Transpl Infect Dis. 2021;23(6):e13726. doi: 10.1111/tid.13726
  20. Lee Loy J, Koratala A, De Los Santos Y, et al. Disseminated toxoplasmosis: a life-threatening complication of inadequate posttransplant prophylaxis. Kidney Int. 2019;95(5):1274. doi: 10.1016/j.kint.2018.10.002
  21. Wons J, Kempen J, Garweg JG. HIV-induced Retinitis. Ocul Immunol Inflamm. 2020;28(8):1259–1268. doi: 10.1080/09273948.2020.1808225

补充文件

附件文件
动作
1. JATS XML

版权所有 © Eco-Vector, 2023

Creative Commons License
此作品已接受知识共享署名-非商业性使用-禁止演绎 4.0国际许可协议的许可。
 


Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).